GRIFOLS reported EUR743.8M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Alcon AG USD 1.39B 5M Jun/2025
Almirall EUR 191.9M 185.49M Mar/2025
Amadeus IT EUR 1.22B 80.9M Mar/2025
Amarin USD 25.13M 1.78M Mar/2025
argenx SE USD 837.21M 127.34M Jun/2025
AstraZeneca USD 11.98B 637M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Cie Automotive EUR 805.54M 79.61M Dec/2024
Demant DKK 8.55B 33M Jun/2025
Ence Energia y Celulosa EUR 122.3M 8.3M Sep/2024
Essilor EUR 8.84B 687M Jun/2025
Ferrovial EUR 4.27B 498M Dec/2024
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Galapagos EUR 61.25M 98.68M Mar/2025
Genmab DKK 868M 195M Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Inditex EUR 5.01B 1.04B Apr/2025
Merck EUR 3.03B 118M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Philips EUR 2.01B 162M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
Smith & Nephew USD 2.09B 19M Jun/2025
UCB EUR 2.46B 520M Dec/2024
Viscofan EUR 219.67M 8.21M Jun/2025